Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference
Grey Wolf Animal Health to Present at The 2023 Bloom Burton & Co. Healthcare Investor Conference
Toronto, Ontario--(Newsfile Corp. - April 13, 2023) - Grey Wolf Animal Health Corp. (TSXV: WOLF) ("Grey Wolf" or the "Company"), a Canadian diversified animal health company, today announced that Angela Cechetto, CEO, is scheduled to present a corporate update at the 2023 Bloom Burton & Co. Healthcare Investor Conference on Tuesday April 25, 2023 at 2:30pm ET at the Metro Toronto Convention Centre in Toronto.
安大略省多伦多--(Newsfile Corp.——2023年4月13日)——加拿大多元化动物健康公司灰狼动物健康公司(TSXV:WOLF)(“灰狼” 或 “公司”)今天宣布,首席执行官安吉拉·切切托计划在2023年Bloom Burton & Co.上发布公司最新情况。医疗保健投资者会议将于美国东部时间2023年4月25日星期二下午 2:30 在多伦多大都会会议中心举行。
Grey Wolf management will also be available for one-on-one meetings during both days of the conference to be held on April 25-26, 2023. Investors interested in meeting with Grey Wolf during the conference should contact the conference coordinator or email investors@greywolfah.com.
在将于2023年4月25日至26日举行的两天会议期间,Grey Wolf管理层也将可以进行一对一的会议。有兴趣在会议期间与Grey Wolf会面的投资者应联系会议协调员或发送电子邮件至 investors@greywolfah.com。
About Grey Wolf Animal Health Corp.
关于灰狼动物健康公司
Grey Wolf Animal Health Corp., headquartered in Toronto, Canada, is a diversified animal health company founded by a veterinarian to bring to market a broad portfolio of products that meets the unmet needs of veterinarians, clinics and pets. The Company's strategy is to in-license, acquire or develop innovative prescription and non-prescription products for commercialization in the veterinarian channel in Canada. For additional information, please visit: .
Grey Wolf Animal Health Corp. 总部位于加拿大多伦多,是一家由兽医创立的多元化动物健康公司,旨在将广泛的产品组合推向市场,以满足兽医、诊所和宠物未得到满足的需求。该公司的战略是许可、收购或开发创新的处方和非处方产品,以便在加拿大兽医渠道进行商业化。欲了解更多信息,请访问:。
For further information, please contact:
欲了解更多信息,请联系:
Angela Cechetto
Chief Executive Officer
E-mail: investors@greywolfah.com
安吉拉·切切托
首席执行官
电子邮件:investors@greywolfah.com
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
多伦多证券交易所风险投资交易所及其监管服务提供商(该术语在多伦多证券交易所风险投资交易所的政策中定义)均不对本新闻稿的充分性或准确性承担责任。
Forward-Looking Statements
前瞻性陈述
This news release includes certain statements that may be deemed "forward-looking statements." All statements in this new release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects," "plans," "anticipates," "believes," "intends," "estimates," "projects," "potential," and similar expressions, or that events or conditions "will," "would," "may," "could," or "should" occur. Forward-looking information in this news release includes statements related to the Company's attendance at the 2023 Bloom Burton & Co. Healthcare Investor Conference. Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
本新闻稿包括某些可能被视为 “前瞻性陈述” 的陈述。除历史事实陈述外,本新新闻稿中涉及公司预计将发生的事件或事态发展的所有陈述均为前瞻性陈述。前瞻性陈述不是历史事实,通常但并非总是以 “期望”、“计划”、“预期”、“相信”、“打算”、“估计”、“项目”、“潜力” 和类似表达方式来识别,或者事件或条件 “将”、“将”、“可能” 或 “应该” 发生。本新闻稿中的前瞻性信息包括与公司出席2023年Bloom Burton & Co.有关的声明。医疗保健投资者会议。前瞻性陈述基于公司管理层在陈述发表之日的信念、估计和观点。除非适用的证券法有要求,否则如果管理层的信念、估计或观点或其他因素发生变化,公司没有义务更新这些前瞻性陈述。
To view the source version of this press release, please visit
要查看本新闻稿的源版本,请访问